Journal article icon

Journal article

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial

Abstract:
Background Vaccination of children and young people against SARS-CoV-2 is recommended in some countries. Scarce data have been published on immune responses induced by COVID-19 vaccines in people younger than 18 years compared with the same data that are available in adults.
Methods COV006 is a phase 2, single-blind, randomised, controlled trial of ChAdOx1 nCoV-19 (AZD1222) in children and adolescents at four trial sites in the UK. Healthy participants a... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1016/s0140-6736(22)00770-x

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Paediatrics
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Paediatrics
Role:
Author
ORCID:
0000-0002-0749-8329
Expand authors...

Contributors

Role:
Contributor
Publisher:
Elsevier Publisher's website
Journal:
Lancet Journal website
Volume:
399
Issue:
10342
Pages:
2212-2225
Publication date:
2022-06-11
Acceptance date:
2022-04-08
DOI:
EISSN:
1474-547X
ISSN:
0140-6736
Pmid:
35691324
Language:
English
Keywords:
Pubs id:
1263717
Local pid:
pubs:1263717
Deposit date:
2022-06-22

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP